Mainz, Germany – Announcing that they have developed more than 90 percent of the vaccine to protect against coronavirus, Prof Dr Uğur Şahin and his wife Dr Özlem Türeci became the hope of the whole world. ” We are on the verge of ending this epidemic, “said Prof Dr Sahin, the” savior of the world crisis.”
It was announced that the Covid-19 vaccine, developed by BioNTech and US-based pharmaceutical company Pfizer, would be below market value. It was reported that the price of the vaccine, which will be administered in two doses, will be $ 19.5 per dose in the United States. Here are all the developments related to the coronavirus vaccine developed by Pfizer and BioNTech.
With the world on its knees in the coronavirus epidemic, and record numbers of cases in almost every country have begun to rise, the news about the vaccine work has finally arrived. According to breaking news, Phase 3 trials of the vaccine developed by pharmaceutical companies Pfizer and BioNTech against Covid-19 have been announced to be 90 percent effective.
The Coronavirus outbreak continues to spread around the world. The total number of cases detected in the outbreak of the new type of coronavirus (Covid-19), which occurred in Wuhan, Hubey province, China and spread around the world, exceeded 51 million 243 thousand.
The coronavirus vaccine developed by BioNTech and American pharmaceutical giant Pfizer, led by Prof Dr Uğur Şahin and his wife Dr Özlem Türeci, based in Mainz, Germany, gave the world hope in an instant.
It reinforced expectations that the epidemic would finally be defeated and that the normal life that was missed was not far away. At a time when cases are running to a new record every day, people are desperate that it will take years to find an effective vaccine, and economic circles are beginning to calculate the next year as a lost year, the news about the vaccine has excited science, the economy and people.
Germany is especially proud that such a vaccine was developed in Germany, while the professor who signed the vaccine The fact that Uğur Şahin and his wife Dr. Özlem Türeci are immigrants showed how meaningless the recent debate against immigrants is and how much labor migration contributes to Germany.
Scientists also stressed that the vaccine, developed under the leadership of Prof Sahin, is very promising. “These data are very excellent and promising, ” said Prof Gerd Faetkenheuer, head of the Department of Infectious Diseases at the University of Cologne.
The development of such a vaccine substance in such a short period of time and the results of clinical examination are incredible,” he said. Florian Krammer, a professor in the Department of microbiology at Mount Sinai in the US, described the clinical research results announced by BioNTech and Pfizer as “a great result.” Marylyn Addo, head of the Department of Tropical Diseases at the Eppendorf Clinic of the University of Hamburg, gave a more careful assessment and stressed that no primary data has yet come in, all data should be evaluated.
Many years of research as well as vaccines against infectious diseases in the history of humanity for the first time in 10 months that’s over 90 percent effective in the development of a vaccine against coronavirus and is seen as a miracle.
“We are on the verge of ending this epidemic,” said Prof Sahin, who believes he has developed the most perfect vaccine against Corona. The German press has already declared Prof Shahin the person who will lead the world out of the crisis. The Bild newspaper used the headline “father of the German vaccine wonder” for Prof Dr Uğur Şahin. The Express newspaper published in Cologne used the title “savior of the world crisis”, commenting that if it is successful, it will also win the Nobel Prize in medicine.
Born in 1965 Alexander, Prof Uğur Şahin came to Cologne, Germany with his family at the age of 4. Prof Uğur Şahin, whose father worked as a worker in the Ford factory, was very impressed by a documentary film he watched on the life of Paul Ehrlich, a German medical scientist who developed chemotherapy against cancer, and decided to study medicine. Sahin, who studied medicine at the University of Cologne, was working with his wife, Dr Özlem Türeci, who he met in Hamburg, on antibodies that switch to defense against diseased cells to beat cancer.
Couples received awards for their significant progress in this area. The couple, who even worked in the lab on the day of their wedding, were alarmed by the lung disease Coronavirus, which originated in Wuhan, China. Prof Shaheen, 55, saw very quickly that the infection would not remain local and would spread rapidly all over the world.
Prof Şahin immediately convened the board of Directors of BioNTech, which he founded in 2008 with his wife Dr Özlem Türeci, and said: “Our new task is to defeat this virus. It will be a humanitarian mission,” he said.
Prof Sahin and Dr Türeci put the study of drug development against cancer on the back burner for a while, rolling up their sleeves to develop an effective and safe vaccine against Coronavirus.
Although the name of Dr. Özlem Türeci, whose father is a doctor from Istanbul, is not at the forefront, he plays an important role in vaccine studies and is the head of research.”the EU Commission will soon sign contracts with these companies to receive up to 300 million doses of the vaccine, “von der Leyen said. the phrase ” used.
BioNTech, the founder of Prof Dr Uğur şahin, who developed the coronavirus vaccine, and Pfizer, the US-based pharmaceutical company, will submit an application for approval for the coronavirus vaccine to the US later this month, following positive data.
Pfizer signed a $ 1.95 billion deal with the U.S. government in July. It was reported that the pricing of this vaccine, administered in two doses in the United States, will be $ 159 per dose, and two doses will be $ 318.
The two companies said in a statement that they plan to apply to the U.S. Food and Drug Administration for emergency approval later this month, noting that the finding is the result of the first independent analysis of any Covid-19 vaccine in Stage 3 trials, the last stage before commercial licensing.
Prof Sahin said he had no interest in increasing his stock and becoming one of the richest in the world.
In a statement, the views, the BioNTech CEO and co-founder Prof Dr Ugur Sahin, an analysis of the first phase of the work of the 3rd Global Vaccine Dec vaccine “Covid-19 provide evidence that can effectively prevent.” stating that, “this innovation is a victory for science and global cooperation efforts. the phrase ” used.
Prof Sahin said: “this is what we wanted to achieve 10 months ago when we set out on the journey to find the vaccine in question. Especially today, when we are all in the middle of a second wave of the epidemic and many of us are subject to restrictions, we understand more and more how important this milestone is on the road to ending this epidemic and restoring a sense of normality for all of us.”he made his assessment.
For Prof Uğur Şahin and Dr Özlem Türeci, co-founders of BioNTech, which developed the vaccine, the news of the “couple who saved the world” made headlines in the World Press.
Prof Shahin’s words,” we are on the verge of ending this epidemic, ” revived the deeply depressed world economy. “The end of the tunnel appeared,” economic experts said.
Germany is especially proud that such a vaccine was developed in Germany, while the professor who signed the vaccine The fact that Prof Uğur Şahin and his wife Dr. Özlem Türeci are of immigrant origin showed how meaningless the recent debate against immigrants is and how much labor migration contributes to Germany.
The world economy was buoyed again by the news of financial markets, while the stock market rose for the first time since March. The German stock index Dax rose 6.5 per cent to 13,297 points, while EuroStoxx50 closed 7.4 per cent higher at 3439 points. It was the highest increase since March. “The end of the tunnel appeared,” German economic experts said. The economic damage will be lower than expected. We expect a better conjuncture,” he assessed.
Scientists also stressed that the vaccine, developed under the leadership of Prof Sahin, is very promising. Head Of The Department of Infectious Diseases of The University of Cologne Prof. Gerd Faetkenheuer said, ” These data are very excellent and promising. The development of such a vaccine substance in such a short period of time and the results of clinical examination are incredible,” he said.
Florian Krammer, a professor in the Department of microbiology at Mount Sinai in the US, described the clinical research results announced by BioNTech and Pfizer as “a great result.”
Marylyn Addo, head of the Department of Tropical Diseases at the Eppendorf Clinic of the University of Hamburg, gave a more careful assessment and stressed that no primary data has yet come in, all data should be evaluated.
To date, vaccines developed against infectious diseases around the world have taken many years, and research results are expected for at least two years to see the side effect. For the first time in human history, the development of a vaccine against coronavirus in as little as 10 months and it is more than 90 percent effective, as well as no significant side effects, is considered a miracle.
The German press has already declared Prof Shahin the person who will save the world from the crisis. The Bild newspaper used the headline “father of the German vaccine wonder” for Prof Uğur Şahin. The Express newspaper published in Cologne used the title saviour of the world crisis, commenting that if it is successful, it will also win the Nobel Prize in medicine.
The stocks of the BioNTech company, headed by Prof Uğur Şahin and his wife Dr Özlem Türeci, rose 20 percent. Prof Şahin said that the increase in his shares and his becoming one of the richest people in the world did not concern him at all and said “we want to create value in the long run”.
Prof Uğur Şahin was very impressed by a documentary film he watched on the life of Paul Ehrlich, the German medical scientist who developed chemotherapy against cancer, and decided to study medicine. Prof Sahin, who studied medicine at the University of Cologne, was working with his wife, Dr Özlem Türeci, who he met in Hamburg, on antibodies that switch to defence against diseased cells to beat cancer. Couples received awards for their significant progress in this area.
Even working at the lab on their wedding day, the pair were alarmed by the lung disease coronavirus, which originated in Wuhan, China. Prof Shaheen, 55, saw very quickly that the infection would not remain local and would spread rapidly all over the world. Prof. Sahin immediately convened the board of Directors of BioNTech, which he founded with his wife Özlem Türeci in 2008, and said: “Our new task is to defeat this virus. It will be a humanitarian mission,” he said.
Prof Sahin and Dr Türeci put the study of drug development against cancer on the back burner for a while, rolling up their sleeves to develop an effective and safe vaccine against coronavirus. Even if the name of Dr. Özlem Türeci, whose father is a doctor from Istanbul, is not mentioned in the news, he plays an important role in vaccine studies and is the head of research.
“Today is a great day for science and humanity,” Albert Bourla, Pfizer’s chief executive, said in a statement.
BioNTech had previously announced plans to produce 100 million more doses of vaccines globally by the end of 2020 and about 1.3 billion by the end of 2021.
Pfizer and BioNTech had signed agreements with the United States, the European Union, the United Kingdom, Canada and Japan to supply the vaccine. The companies had signed a $ 1.95 billion contract to provide the U.S. government with 100 million doses of the vaccine starting this year.
Spain’s Health Minister said Pfizer and BioNTech expect the vaccine to reach their countries by early 2021, while Germany plans to buy 100 million doses of the vaccine.
In the US, Pfizer and BioNTech plan to use the vaccine in the country. Donald Trump, who lost the US elections yesterday, despite intense election agenda, has made a statement with the vaccine; US, coronavirus (Covid-19) SE of the epidemic coronavirus vaccine developed by Pfizer and BioNTech an initial dose of 100 million to 1 billion and bought $ 95 million announced it has paid. Shares of the US drugmaker are up 14 per cent today.
Biontech-Pfizer’s Covid-19 vaccine, Ankara University Faculty of Medicine Department of anesthesia and reanimation faculty member and member of the Scientific Board Prof Dr. Necmettin Ünal conveyed his experience. Unal explained that the vaccine itself does not cause side effects, and it will be observed by the company for 2 years after the vaccine.
The couple who could save the world: Billionaire husband and wife who are so devoted to research that they spent their wedding day in the lab win race to produce Covid vaccine that’s given hope to millions.
The married physicians Ugur Sahin and Oezlem Tuereci bonded over their love of medical research. The couple are being hailed as the ‘dream team’ behind the world’s hopes for a coronavirus vaccine.
Physicians Ugur Sahin and Oezlem Tuereci, who bonded over their love of medical research, are the married couple behind the Covid-19 vaccine that could change the world.
Mr Sahin came from humble roots to build two billion-dollar companies but still rides to work on his mountain bike.
Now the ‘modest’ 55-year-old physician turned chief executive of a German biotech firm and his wife Ozlem Tureci, 53, a fellow board member of BioNTech, are being hailed as the ‘dream team’ behind the world’s hopes for a Covid vaccine.
The global race to find a Covid-19 vaccine took a leap forward yesterday when pharma companies Pfizer and BioNTech claimed their experimental jab is 90 per cent effective.
Born in Turkey, Mr Sahin was raised in Germany, where his parents worked in a Ford factory. Trained as a doctor, Mr Sahin became a professor and researcher focused on immunotherapy.
He worked at teaching hospitals in Cologne and the south western city of Homburg, where he met immunologist Miss Tuereci during his early academic career. Medical research and oncology became a shared passion.
Miss Tuereci, the daughter of a Turkish physician who had migrated to Germany, once said in an interview that even on the day of their wedding, both made time for lab work.
Together they honed in on the immune system as a potential ally in the fight against cancer and tried to address the unique genetic makeup of each tumour.
Life as entrepreneurs started in 2001 when they set up Ganymed Pharmaceuticals to develop cancer-fighting antibodies, but Mr Sahin – by then a professor at Mainz university – never gave up academic research and teaching. Ganynmed was sold to Japan’s Astellas in 2016 for $1.4 (£1.06) billion.
Mr Sahin and Miss Tuereci co-founded BioNTech in 2008, with the aim of pursuing a much broader range of cancer immunotherapy tools.
The Bill & Melinda Gates Foundation has invested $55 (£41.8) million in the company, which also works on HIV and tuberculosis programmes.
Colleagues describe Mr Sahin as a calm and measured man who avoids checking the company’s share price and is more interested in reading scientific journals.
He and his wife now figure among the 100 richest Germans, according to German newspaper Welt am Sonntag.
But Matthias Kromayer, a board member of venture capital firm MIG AG, whose funds have backed BioNTech, said: ‘Despite his achievements, he never changed from being incredibly humble and personable.’
He added Mr Sahin would typically walk into business meetings wearing jeans and carrying his signature bicycle helmet and backpack with him.
Matthias Theobald, a fellow oncology professor at Mainz university who has worked with Mr Sahin for 20 years, said: ‘He is a very modest person.
‘Appearances mean little to him. But he wants to create the structures that allow him to realise his visions and that’s where his aspirations are far from modest.’
The PM tonight tried to cool hopes of an early end to lockdown after Pfizer and BioNTech revealed that early results from a massive clinical trial suggest nine out of 10 people who get their jab are protected by it.
The UK could get 10million doses of coronavirus vaccine by Christmas, with expert raising expectations that the life could be ‘back to normal’ by the Spring.
The FTSE 100 index is on track for its best day since March, with shares in airlines and hospitality firms spiking globally – although Zoom saw its value plunge.
At a press conference this evening, Boris Johnson said the UK was ‘towards the front of the pack’ to get the critical jabs.
However, he warned that the biggest mistake the country could make now was to ‘slacken our resolve’. ‘Now it is more important than ever to follow the rules,’ he said.
Mr Johnson referred to his previous comments about the ‘distant bugle of the scientific cavalry coming over the brow of the hill’ to salvage the situation.
‘I can tell you that tonight that toot of the bugle is louder, but it’s still some way off, we absolutely cannot rely on this news as a solution,’ he said.
‘The biggest mistake we could make now would be to slacken our resolve at a critical moment.’
Pfizer’s chairman hailed the breakthrough a ‘great day for science and humanity’ while independent experts said the results were ‘excellent’ and ‘really impressive’.
Pfizer and BioNTech are expected to apply for approval to give out the jab in the US as soon as possible, but they must wait for long-term safety data to be completed. There are also concerns about the logistical challenges of distributing huge numbers of doses, which must be stored at around minus 70 degrees centigrade.
Pfizer and German partner BioNTech are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine.
They said that 94 people in a trial of more than 43,000 have so far tested positive for Covid-19, and that over 90 per cent of those did not receive the real vaccine.
They were in the placebo group, where people are given a fake vaccine so that what happens to them can be compared with those who get the real thing. Pfizer’s trial has split the participants half and half across the placebo and vaccine groups.
The companies have not revealed the exact number but a 90 per cent efficacy rate suggests that no more than eight people who got the vaccine caught the virus, compared to 86 of those who received a fake jab.
Pfizer’s next step is expected to be to apply for ’emergency use authorisation’ in the US, for which they will have to go to the Food and Drug Administration (FDA) once they have two months’ worth of safety data — expected to be complete by the end of this month.
The US government’s top infectious disease experts, Anthony Fauci, said the results were ‘just extraordinary’, and suggested other vaccines had strong prospects as they used the same approach.
‘Not very many people expected it would be as high as that,’ he said. ‘It’s going to have a major impact on everything we do with respect to COVID.’
England’s chief medical officer, Chris Whitty, said it was ‘reason for optimism in 2021’ but warned it was essential the country continues to ‘suppress’ coronavirus now.
‘Preliminary news that the Pfizer/BioNTech vaccine is effective demonstrates the power of science against COVID,’ he tweeted. ‘We must see the final safety and efficacy data, but it is very encouraging. It is essential we continue to suppress COVID, but it is a reason for optimism for 2021.’